Media Summary: Prof. Thomas Rades, University of Copenhagen, talks about polymers and small molecules in the process of stabilizing ... For more information, visit www.austinpx.com/kinetisol The KinetiSol™ Technology generates 20 June 2023 This webinar is part of the LINXS Biophysics of

Optimizing Drug Loading In Amorphous - Detailed Analysis & Overview

Prof. Thomas Rades, University of Copenhagen, talks about polymers and small molecules in the process of stabilizing ... For more information, visit www.austinpx.com/kinetisol The KinetiSol™ Technology generates 20 June 2023 This webinar is part of the LINXS Biophysics of For more information, please visit us at: Prof. Anette Müllertz, University of Copenhagen, speaks about the influence of The talk was given within the NordicPOP WP2/CRS Nordic Local Chapter webinar by Prof. Thomas Rades, University of ...

Our Gattefossé Group Director, Pharmaceuticals, Alexandre Gil, talks about the benefits of formulating Self-Emulsifying How do you choose the right CDMO technology to improve

Photo Gallery

Optimizing Drug Loading in Amorphous Solid Dispersions
Drug Loading in Amorphous Solid Dispersions: Maximizing Bioavailability While Minimizing Pill Burden
Stabilizing Amorphous Drugs:
Modelling amorphous solid dispersion release mechanisms
Kinetisol Amorphous Solid Dispersions | AustinPx
A journey into the world of crystalline and amorphous pharmaceuticals with Ines C. B. Martins
Recent Advances in Amorphous Solid Dispersions: Formulation and Characterization Strategies
Role of Excipients in Design of Solid Amorphous Dispersions - Thomas Durig
Optimizing Lipid-based Drug Delivery Systems - Influence of Drug Load and Composition
Amorphous Drug Research and Development by Thomas Rades
What are the benefits of formulating SEDDS vs Amorphous Solid Dispersions (ASD)? | Gattefossé
Challenging the Conventional Tablet: Amorphous vs Crystalline Drugs | Vikram Joshi
View Detailed Profile
Optimizing Drug Loading in Amorphous Solid Dispersions

Optimizing Drug Loading in Amorphous Solid Dispersions

Amorphous

Drug Loading in Amorphous Solid Dispersions: Maximizing Bioavailability While Minimizing Pill Burden

Drug Loading in Amorphous Solid Dispersions: Maximizing Bioavailability While Minimizing Pill Burden

Register for this webinar: ...

Stabilizing Amorphous Drugs:

Stabilizing Amorphous Drugs:

Prof. Thomas Rades, University of Copenhagen, talks about polymers and small molecules in the process of stabilizing ...

Modelling amorphous solid dispersion release mechanisms

Modelling amorphous solid dispersion release mechanisms

Drug

Kinetisol Amorphous Solid Dispersions | AustinPx

Kinetisol Amorphous Solid Dispersions | AustinPx

For more information, visit www.austinpx.com/kinetisol The KinetiSol™ Technology generates

A journey into the world of crystalline and amorphous pharmaceuticals with Ines C. B. Martins

A journey into the world of crystalline and amorphous pharmaceuticals with Ines C. B. Martins

20 June 2023 This webinar is part of the LINXS Biophysics of

Recent Advances in Amorphous Solid Dispersions: Formulation and Characterization Strategies

Recent Advances in Amorphous Solid Dispersions: Formulation and Characterization Strategies

Recent Advances in

Role of Excipients in Design of Solid Amorphous Dispersions - Thomas Durig

Role of Excipients in Design of Solid Amorphous Dispersions - Thomas Durig

For more information, please visit us at: http://www.ashland.com/pharmaceutical/learning-center.

Optimizing Lipid-based Drug Delivery Systems - Influence of Drug Load and Composition

Optimizing Lipid-based Drug Delivery Systems - Influence of Drug Load and Composition

Prof. Anette Müllertz, University of Copenhagen, speaks about the influence of

Amorphous Drug Research and Development by Thomas Rades

Amorphous Drug Research and Development by Thomas Rades

The talk was given within the NordicPOP WP2/CRS Nordic Local Chapter webinar by Prof. Thomas Rades, University of ...

What are the benefits of formulating SEDDS vs Amorphous Solid Dispersions (ASD)? | Gattefossé

What are the benefits of formulating SEDDS vs Amorphous Solid Dispersions (ASD)? | Gattefossé

Our Gattefossé Group Director, Pharmaceuticals, Alexandre Gil, talks about the benefits of formulating Self-Emulsifying

Challenging the Conventional Tablet: Amorphous vs Crystalline Drugs | Vikram Joshi

Challenging the Conventional Tablet: Amorphous vs Crystalline Drugs | Vikram Joshi

Amorphous

Drug Bioavailability Solutions from a CDMO You Can Trust

Drug Bioavailability Solutions from a CDMO You Can Trust

How do you choose the right CDMO technology to improve